News

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...
FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...
Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool ...
The U.S. Food and Drug Administration plans to integrate generative artificial intelligence across all its centers by June 30, 2025, following a successful pilot program. Here are five things to know: ...
OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...